Chemical Component Summary

NameN-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
Identifiers~{N}-phenyl-~{N}-[1-(2-phenylethyl)piperidin-4-yl]propanamide
FormulaC22 H28 N2 O
Molecular Weight336.47
TypeNON-POLYMER
Isomeric SMILESCCC(=O)N(c1ccccc1)C2CCN(CC2)CCc3ccccc3
InChIInChI=1S/C22H28N2O/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19/h3-12,21H,2,13-18H2,1H3
InChIKeyPJMPHNIQZUBGLI-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count53
Chiral Atom Count0
Bond Count55
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB00813 
NameFentanyl
Groups
  • approved
  • illicit
  • investigational
  • vet_approved
DescriptionFentanyl, a potent opioid agonist, was developed in the 1950s to fill a need for strong and rapid analgesia.[A179542] Because of these characteristics, fentanyl is commonly used to treat chronic cancer pain or in anesthesia.[Label,L6598,L6601,L6604,L6607,L922,L6610,L6613] Fentanyl is related to other opioids like [morphine] and [oxycodone]. Fentanyl's high potency has also made it a common adulterant in illicit drugs, especially heroin.[A179542] In 2017, 47600 overdose deaths in the United States involved some opioid (over 2/3 of all overdose deaths).[L6748] Opioid overdoses kill an average of 11 Canadians daily.[L6751] Fentanyl was FDA approved in 1968.[Label,L6598,L6601,L6604,L6607,L922,L6610,L6613]
Synonyms
  • N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide
  • Fentanyl
  • Fentanyl CII
  • Fentanilo
  • 1-phenethyl-4-N-propionylanilinopiperidine
Brand Names
  • Fentora
  • Fentanyl - NOVAPLUS
  • Instanyl
  • Duragesic 100
  • Pat-fentanyl Mat
IndicationFentanyl intravenous or intramuscular injections are indicated for short term analgesia during induction, maintenance, and recovery from general or regional anesthesia.[Label] These injections are also used with a neuroleptic for premedication, induction, and as an adjunct to maintenance of anesthesia.[Label] Finally, fentanyl intravenous or intramuscular injections are used with oxygen for anesthesia in high risk patients.[Label] Fentanyl sublingual tablets, transmucosal lozenges, buccal tablets, sublingual sprays, transdermal systems, and nasal sprays are indicated for the management of breakthrough pain in opioid tolerant cancer patients who require around the clock pain management.[L6598,L6601,L6604,L6607,L922,L6610]
Categories
  • Adjuvants
  • Adjuvants, Anesthesia
  • Agents that produce hypertension
  • Agents that reduce seizure threshold
  • Analgesics
ATC-Code
  • N01AH01
  • N02AB03
  • N01AH51
CAS number437-38-7

Drug Targets

NameTarget SequencePharmacological ActionActions
Mu-type opioid receptorMDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRT...unknownagonist
Delta-type opioid receptorMEPAPSAGAELQPPLFANASDAYPSACPSAGANASGPPGARSASSLALAI...unknownagonist
Kappa-type opioid receptorMDSPIQIFRGEPGPTCAPSACLPPNSSAWFPGWAEPDSNGSAGSEDAQLE...unknownagonist
P-glycoprotein 1MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...unknown
Cytochrome P450 3A4MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
CCDC/CSDUGIYEP
PubChem3345
ChEBICHEBI:119915
ChEMBLCHEMBL596
PharosCHEMBL596